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Abstract
The increasing use of the intra aortic balloon pump is attributed to the relatively easy percutaneous insertion and
the low threshold of use over the past few years, especially in elderly patients with multi-vessel diseases and an
affected ejection fraction.
Unfortunately, the clinical assessment of the complications associated to the use of this supporting device,
underestimates the frequency of such complications.
This report has looked at the current literature and attempt to identify incremental risk factors related to the
development of adverse effects during support with an intaaortic balloon pump.
The paper concludes that in contrary to early reports, newer studies have shown that complications following
intraaortic balloon pump treatment, is decreasing. Moreover the literature suggests that the thrombosis and
infective complications are relevant to the duration of the pump treatment, while the ischemic problems of the
limbs are mostly linked to the atherosclerotic status of the common femoral artery.
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Introduction
The complication rates when using an intra aortic bal-
loon pump are high and may account for up to 50%
according to Harvey et al [1], with an average 20-30%
[2,3].
Rates depend on the definition of complications as
well as on whether the data are collected in advance or
not. Certain researchers argue that clinical studies may
significantly underestimate the actual frequency of com-
plications. The high occurrence of ischemia in certain
studies is possibly related to the lower mortality rate.
On the contrary, the low occurrence of ischemia in
some other studies, may be possibly linked to the fact
that the patients died following a cardiogenic shock
before the development of the clinical diagnosis of vas-
cular complications.
Thrombocytopenia is currently the commonest com-
plication occuring in 50% of the patients followed by
fever in almost 40% of the cases [2]. Bleeding is also
common with aorto-iliac artery injury and dissection,
thromboembolism, distal leg ischaemia and balloon
entrapment-rupture, to occur less frequently. Despite
this, over 70,000 IABP insertions are undertaken
annually in the United States alone, with an incidence of
between 5-10% amongst all patients undergoing cardiac
surgery.
Issues related to the “actual incidence” of the
development of complications
Various researchers have reported only the clinically
occurring morbidity during IABP treatment, while
others have defined the complications in a way that
encompasses all incidents, even those that have been
entirely solved.
Moreover, some researchers have moved even further
to include incidents where the causal role of the treat-
ment with IABP was not clear. In a perspective study,
Alderman et al [4] note limb ischemia in 42% of the
cases where balloon pump was inserted.
Similarly, A. Kantrowitz et al have examined the cases
of 733 patients from 1967 through to 1982 and found a
total complication rate of 45% [5].* Correspondence: hparissis@yahoo.co.uk
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Bregman et al [6] suggest that morbidity resulting
from treatment with balloon pump may go unnoticed.
The main reason for that can be the short survival time
after treatment with IABP might or the overall unani-
mity concerning the exclusion of patients on whom the
insertion of intra aortic balloon pump had failed (Alpert
et al) [7].
Alvarez et al [8] have retrospectively followed-up 303
patients over a decade and reported a total number of
99 patients who had complications (32.6%). However,
some straightforward severe clinical indications, as in
loss of pulse, were not considered to be a complication.
Moreover, the paper does not make clear whether com-
plications after failed femoral attempts (7.5%) have been
included in the study.
Goldberg et al [9] argue that complication rates after
failed attempts are possibly equal or higher than those
of the patients with a successful IABP insertion. This is
what Riaz et al [10] have also underlined. They reported
a higher consequential complication rate in patients that
underwent unsuccessful surgical interventions.
The fact that injuries resulting from the activity of the
intra aortic balloon pump could go clinically undiag-
nosed despite their severity has been mentioned in an
important paper by Isner et al [11]. They re-examined a
total of 45 necropsy patients, who had undergone a pla-
cement of intra aortic balloon and died within 105 days
after the balloon insertion.
Nine patients had a dissection of the aortoiliac axis
and in none of them was the dissection suspected
before their death. Insertion in 4 of the 9 patients was
performed “resistance-free”. In one of the 3 patients
that presented arterial perforation no complication was
manifested from the insertion of the balloon. Two of
the 3 patients that had developed intravascular throm-
bosis no clinical suspicions were raised before death.
Three patients presented clinically silent arterial
emboli. They concluded that out of the 20 complica-
tions (in 16 patients) only 4 (20%) had been suspected
before death.
Literature review of the risk factors
Age
In theory, atherosclerosis develops parallel with the
aging process and consequently one could conclude that
the effect of vascular complications is higher in older
ages. However, this speculation is an object of dispute
throughout the relevant literature.
Gottlieb et al [12], undertook a multivariate analysis of
risk factors in order to identify the patients at high risk
for IABP related complications. They concluded that
advanced age was correlated to unsuccessful insertion
attempts, but it was found that it had nothing to do
with the occurrence of major vascular complications, in
a retrospective study in which 206 consecutive patients
underwent an attempt of insertion of intraoartic balloon.
Therefore, this is not a significant risk factor.
Goldberger et al [9], mentioned their experience with
112 consecutive patients that underwent IABP counter-
pulsation. 11 out of 40 patients (27.5%) aged over 70
years presented complications whereas only 12 out of 72
(16.7%) patients aged less than 70 years had
complications.
Gender
The smaller size of the femoral artery justifies the higher
complication rate in women according to some
researchers, such as Collier et al [13] and Beddermann
et al [14]. Moreover, the same researchers concluded
that men without peripheral vascular disease had lower
incidence of complications related to the intra aortic
balloon pump (IABP).
Shahian [15] reported that the gender was the most
strongly related variable to morbidity associated with
intra aortic balloon pump.
A univariate analysis of a group of 249 patients in a
prospective study performed by Funk et al [16], revealed
that the female gender is a significant predictor for the
development of major complications. According to the
same researchers, women with peripheral vascular dis-
ease and diabetes constitute the group being at the high-
est risk to present complications associated with the
intra aortic balloon pump (83%).
History of peripheral vascular disease
Peripheral vascular disease is a risk factor for adverse
outcome.
Pace et al [17], reexamined 104 cases of patients who
had been treated over a period of 6 years. Eleven (47%)
of the 23 patients with peripheral vascular disease suf-
fered arterial complications. Iverson et al [18], examined
395 cases of patients that required IABP support. Out of
72 patients who sustained complications, 29 (40%) had a
history of peripheral vascular disease.
In a retrospective study assigned to Kvilekval et al
[19], 144 cases of patients that were treated with IABP
were re-examined. Patients were divided into two
groups. The first group had 20 patients with a history of
peripheral vascular disease. The second group had 124
patients, without such a history. Twelve severe compli-
cations were observed in the first group (60% of the
total 20 insertions) and seven in the second group (5%
of the total 133 insertions). Moreover, the researchers
examined the nature of the complications in both
groups. They noticed more frequent embolic, obstruc-
tive and “technical” complications in the first group.
Alderman [4 and Skillman [20] have calculated that
patients suffering from peripheral vascular disease run
1.3-1.9 higher risk to develop limb ischemia compared
to patients without a history of vascular disease.
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Insertion methods
Contradictory views have been published throughout the
relevant literature.
Alcan et al [21] compared the conventional surgical
and percutaneous insertion of intra aortic balloon pump
in 151 cases of patients. Percutaneous insertion was
attempted in 51 patients, while surgical insertion in 100
patients. The success rate in the percutaneous group
was 90.2% (46 of 51) and 90% in the second group (90
of 100). The severe complications rate was found to be
almost equal for both techniques (15.2 in the first group
and 15.6 in the second group).
Harvey et al [1], after assessing 89 consecutive patient
cases concluded that the rate and severity of complica-
tions of the percutaneous insertion of intra aortic bal-
loon pump is similar to those of the conventional
insertion of an IABP. Twenty-three patients sustained
major complications and 14 sustained minor ones. Also,
McCabe et al [22], after reviewing 82 patients who
underwent surgical placement of an intra aortic balloon
pump in the femoral artery, he mentioned a total com-
plications rate of 23%.
On the contrary, Iverson et al [18] associated the per-
cutaneous placement with significant decrease in com-
plications. They reexamined 395 cases that required
hemodynamic support with an intra aortic balloon. The
following three methods of insertions were applied: sur-
gical cut down, percutaneous approach and intraopera-
tive placement in the ascending aorta. The insertion
method proved to be an important factor regarding the
occurrence of vascular complications. Patients in whom
the intraaortic balloon pump was placed through surgi-
cal cut down had almost twice as many complications
as those patients who had percutaneous placement (32
versus 19%). Despite the fact that the specific paper
defends the percutaneous placement, it did not manage
to explain the final outcomes and also failed to identify
the complication rate for the group of patients whose
balloon was placed intraoperatively in the ascending
aorta.
Other studies have shown an increase in the complica-
tions associated with the balloon when employing the
percutaneous approach. In a multivariate risk factor ana-
lysis Sanfelippo et al [23] concluded that the percuta-
neous insertion approach was associated with double
number of major complications. No serious explanation
has been formulated till now on this issue. However,
Goldberg et al [9] explain this contradiction by suggest-
ing that when removing a surgically placed intra aortic
catheter, a Fogarty embolectomy is performed in an
attempt to remove the thrombotic material.
The transthoracic intra aortic balloon pump insertion
is said to be associated with a decreased rate of vascular
complications of the lower extremes. This has been
used as the basis for the speculation that following a
treatment with an intra aortic balloon, there is high
morbidity when placing a balloon percutaneously.
McGeehin et al [24] reviewed 39 patients who under-
went transthoracic support with intra aortic pump. Five
patients sustained complications possibly associated with
the procedure. Complications included mostly neurolo-
gical damage and mediastinal infection.
Hazelrigg et al [25] published a retrospective review of
100 cases of transthoracic pumps. They also studied 55
cases of patients that had been placed an intra aortic
balloon through the femoral vein. They mentioned a
zero morbidity rate attributed to lower limb ischemia in
the first group, while the rate was 16.3% in the second
group. Although the duration of the balloon treatment
for these two groups is not available for comparison,
one could speak unfavourably for the percutaneous
insertion due to the huge limb ischemic effect in the
second group. The neurological incidents due to throm-
boembolism (resulting from in vivo formation of a clot
or from managing the atherosclerotic aorta, or gaseous
emboli) or hypotension, were reported to be similar in
the two groups.
History of diabetes mellitus
Vascular complications and wound botulism are higher
in patients suffering from diabetes compared to non-dia-
betic people.
In the framework of a comprehensive research, Wasfie
et al [26] investigated 733 cases of patients undergoing
intra aortic balloon pump treatment. One hundred
thirty two of the patients were diabetics, 51 were on
special diet, 46 were taking hypogylcemic drugs per os
and 35 were insulin dependent. Vascular complications
associated with the IABP method occurred in 35% of
the insulin-dependent diabetics, in 18% of the “other
types of” diabetics and in 14% of the non-diabetic
patients. Wound infection was 37, 22 and 25% respec-
tively. Finally, the premature mortality rate was similar
for the diabetic and non-diabetic people.
However, the results of the univariate regression ana-
lysis of 46 cases by Funk et al [16] showed that diabetes
mellitus was closely associated with lower limb ischemia.
They concluded that a man without peripheral vascular
disease or diabetes mellitus had 29% chances to sustain
lower limb ischemia, while a woman with diabetes melli-
tus and peripheral vascular disease had 83% chances to
present with this specific complication.
Several other risk factors
Low cardiac output, cardiogenic shock, hypertension,
smoking, obesity, inotropic support, increased systemic
vascular resistance, ankle-brachial pressure index < 0.8.
All these factors have been blamed for being etiologic
risk factors for the occurrence of complications. In the
aforementioned paper by Funk et al [16] obesity, low
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cardiac output, increased systemic vascular resistance
and the use of inotropic support have been correlated to
the incidence of vascular complications. Vascular com-
plications were also higher in patients with hyperten-
sions (27 v. 20%).
Sheathless balloon insertion: Effect on vascular
complications
Apart from the percutaneous placements of the intra
aortic balloon, another two major steps have been the
reduction of the balloon’s diameter and the sheathless
technique.
Although there has been recent progress in further
reduction of the catheter’s internal diameter with a bal-
loon at 7.5Fr, there has been no similar reduction in the
outer diameter of the catheter, which is still 11 Fr. The
use of a sheathless balloon overcomes this obstacle. As
far as the impact of this technique on vascular compli-
cations, Nash et al [27] mention a limb ischemia rate of
10%. Furthermore Erdogan et al [28] recommend the
use of the sheathless insertion technique in high-risk
patients, particularly those with peripheral vascular dis-
ease and diabetes.
The duration of the IABΡ treatment
In the series of Isner et al [11], 12 of the 20 complica-
tions (60%) occurred at the time of the balloon’s inser-
tion. Easy insertion of the balloon does not exclude the
possibility of severe complications. In this series, 9
patients were identified with aortoiliac dissection, how-
ever in four of the nine patients, the insertion of the
device was free of resistance or other difficulties.
Six patients presented thromboembolism when the
balloon was in action and one presented with focal
sepsis.
Contrary to the above, Hedenmark el al [29] analyzed 90
cases of patients requiring IABP treatment over a 5-year
period and concluded that most of the complications
occurred at the time of the counterpulsation; specifically
in 14 patients (15.55%). However, these researchers failed
to describe the anti-thombotic status during the operation
of the balloon and to mention whether the vascular com-
plications were a result of thrombosis or plaque rupture,
thus contributing to embolic consequences.
The fact that there is a dispute among researchers
regarding the relation between the duration of the IABP
treatment and the occurrence of complications does not
come as a surprise. The duration of use was the only
variable associated with the balloon and which could be
considered to be significant (p = 0.051) in the papers
published by Funk et al [16]. In patients with limb
ischemia, the mean counterpulsation was 49.5 hours
compared to a mean value of 42.5 hours in patients
without ischemia.
Freed et al [30] analyzed 733 consecutive patients in
the period from 1967 to 1982, paying special attention
to the complications during the prolonged circulatory
support using an intra aortic pump. Twenty seven
patients were supported for over 20 days. They con-
cluded, that complications were more frequent in
patients of prolonged support.
Vascular complications were 37% compared to 15% in
those who were supported for less than 20 days. Similar
conclusions were reached by Iverson et al [18], and
more specifically, patients requiring support through a
balloon for over 60 hours presented 1.5 times higher
complication rate than those that required support for
less than 60 hours (32 compared to 21%). McEnany et
al [31] also agree that time is a significant factor regard-
ing the occurrence of complications associated with the
balloon. They stated that 17.7% of the patients that sur-
vived, subsequently presented some complication asso-
ciated with the balloon, and a complication associated
with the balloon has occurred in 5.9% of the patients
that died while the balloon had not yet been removed.
The highest complication rate of 23.2% occurred in
patients from whom the balloon had been removed and
later they died. In these patients, the mean duration of
treatment via an IABP was longer (average > 6 days).
They concluded that septic and thrombotic complica-
tions are directly related to the duration of the support
using an IABP.
Moreover, even the early vascular complications (clau-
dication, nerve paresis and delayed vascular and neuro-
logical symptoms) identified during the postoperative
follow-up have also been reported to be associated with
the duration of the treatment with IABP (Felix etal)
[32].
IABP and peripheral circulation
By enlarge, the peripheral blood flow is determined by
the pressure, resistance, length and internal friction.
The balloon inflation during diastole augments the
blood pressure, which in its turn increases the arterio-
venous gradient and improves flow. Moreover, the
inflation of the balloon at diastole causes displacement
of blood volume and thus the activation of the aortic
barro-receptors inhibits the medullary vasoconstrictor
reflex.
Peripheral resistance is reduced, resulting in the
improvement of the blood flow.
Landreneau et al [33] studied the splanchic blood
flow response to intra aortic balloon pump assist of
prolonged hemorrhagic shock. They concluded that
the intra aortic pump during the hemorrhagic shock
seems to improve the vasokinetic control of the
splanchnic blood flow, by eliminating the effect of
hyperaemic reperfusion and thus resulting in less
reperfusion injury.
Hilberman et al [34] studied the impacts of the intra
aortic pump on the postoperative renal function in
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humans. They showed a postoperative improvement
of the renal reperfusion in humans during
counterpulsation.
Swartz et al [35] studied the effect of perirenal balloon
placement on renal blood flow. They found a mean
reduction of 66% while the balloon was in the renal site.
Rastan et al [36] using CT scans identified IABP malpo-
sition to be a common finding. “Anatomic to balloon”
length miss-match was found in 68.2% of the cases, with
subsequently severe adverse effects. Finally, clinical
reports of intra-abdominal ischemia due to “anatomic-
to-balloon” device length mismatch are reported but
limited [37].
Conclusion
Due to the nature of the IABP the main complications are
related to vascular injury, with studies suggesting overall
angio-ischaemic complications of between 8-18% with
major limb ischaemia reported to be less than 1% [38].
In general, embolic complications are said to be asso-
ciated mainly with the insertion process and less with
pumping, or removal. On the contrary, bacterial infec-
tions and thrombotic complications are mainly related
to the actual time of the treatment with the intra aortic
balloon devise.
Historically support with IABP has been associated
with high complication rate, however newer studies [39]
have shown low incidence of major adverse events. Phy-
sicians therefore should have little reluctance to use
IABP in high-risk patients.
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